TAIYO HOLDINGS (4626) FY2027 Q1 Earnings Report

Quick View

Executive Summary

This was a strong earnings period, achieving higher revenue and profit as well as substantial earnings growth, primarily driven by increased revenue and improved profitability in the Electronics Business. Revenue was ¥39.02B (+17.6% YoY), Operating Income was ¥10.50B (+48.9%), Ordinary Income was ¥11.22B (+68.5%), and Net Income was ¥7.51B (+62.0%). The increase in cost of sales (+8.5%) was substantially below revenue growth, resulting in operating leverage and an improvement in the Operating Margin to 26.9%, compared with 21.3% in the previous year.

Factors Affecting Earnings Performance

【Revenue】Revenue was ¥39.02B, an increase of +17.6% YoY. The core Electronics Business grew to ¥28.05B (+26.2%), accounting for the majority of the company-wide revenue increase of ¥5.84B. Meanwhile, the Medical and Pharmaceutical Business declined to ¥9.20B (-2.3%), indicating that growth trends were not uniform across businesses. Other businesses, including ICT&S, expanded to ¥1.90B (+17.7%).

【Profit and Loss】As the increase in cost of sales (+8.5%) was substantially below the growth in revenue, the gross margin improved to 51.5% from 47.3% in the previous year. The SG&A ratio also declined to 24.5% from 26.1%, and Operating Income increased to ¥10.50B (+48.9%), exceeding the pace of revenue growth. Ordinary Income reached ¥11.22B (+68.5%), partly due to improved non-operating income and expenses. However, the recognition of an extraordinary loss of ¥0.90B reduced Profit Before Tax from Ordinary Income, resulting in Net Income of ¥7.51B (+62.0%). Revenue and profit both increased.

Segment Analysis

The Electronics Business generated Revenue of ¥28.05B (+26.2%) and segment profit of ¥9.76B (+57.4%). Its margin improved substantially to 34.8% from 27.9% in the previous year, and the business accounted for 91.5% of reported segment profit, making it the primary driver of company-wide earnings growth. The Medical and Pharmaceutical Business recorded Revenue of ¥9.20B (-2.3%) and segment profit of ¥0.77B (-44.0%). Its margin declined to 8.4% from 14.6%, resulting in lower revenue and profit. Other businesses, including ICT&S, recorded Revenue of ¥1.90B (+17.7%) and profit of ¥0.14B, returning to profitability from a loss of ¥-0.03B in the previous year. The increasing concentration of profits in the Electronics Business is notable as a structural change within the business portfolio.

Key Financial Indicators

【Profitability】The 26.9% Operating Margin improved by approximately 566bp from 21.3% in the same period of the previous year, while the Net Profit Margin also increased to 19.2% from 14.0%, an improvement of approximately 525bp. Annualized ROE remained high at 23.8%, with operating leverage resulting from the higher gross margin and lower SG&A ratio leading the improvement in profitability.【Cash Flow Quality】Annualized DSO was 88 days, annualized DIO was 112 days, and annualized CCC was 144 days, indicating that accounts receivable and inventories are expanding during a period of revenue growth. Accounts receivable stood at ¥37.51B (+9.3% YoY), while inventories were ¥10.72B (+6.8%).【Investment Efficiency】Annualized total asset turnover was 0.737x, complementing the high-margin earnings structure. Financial leverage was 1.68x, which was not excessive, indicating that the high ROE was primarily supported by improved profitability.【Financial Soundness】The Equity Ratio increased to 59.6% from 57.3% in the previous year. The Debt/Capital ratio was 22.8%, and interest coverage was 57.7x, indicating substantial capacity to withstand interest payments. Cash and deposits were ¥45.70B, accounting for 21.6% of total assets.

Cash Flow Analysis

As no cash flow statement has been disclosed, funding trends are assessed based on changes in the balance sheet. Cash and deposits increased to ¥45.70B from ¥43.20B in the same period of the previous year, indicating an expansion of the funding base. Meanwhile, accounts receivable increased to ¥37.51B (+9.3% YoY) and inventories to ¥10.72B (+6.8%) alongside revenue growth, indicating a structure in which funds tend to remain tied up in working capital, with annualized CCC at 144 days. Accounts payable increased to ¥11.55B (+21.6%), with the increase in trade payables partially offsetting working capital requirements. Long-term borrowings declined to ¥35.58B from ¥41.10B in the previous year, reducing reliance on long-term funding, while short-term borrowings increased to ¥1.75B (+37.2%). Overall, the expansion of accounts receivable and inventories accompanying revenue growth represents a structure in which future cash-generation capacity will be influenced by working capital trends.

Quality of Earnings

Ordinary Income exceeded Operating Income by ¥0.72B, because non-operating income of ¥1.26B exceeded non-operating expenses of ¥0.55B. Non-operating expenses included interest expenses of ¥0.18B and foreign exchange losses of ¥0.14B, both of which are recurring in nature. Meanwhile, an extraordinary loss of ¥0.90B was recognized, reducing Profit Before Tax from Ordinary Income; this extraordinary loss is classified as a temporary factor. Consequently, Net Income growth (+62.0%) was below Ordinary Income growth (+68.5%), with the divergence primarily attributable to the extraordinary loss. Comprehensive Income was ¥10.03B, exceeding Net Income of ¥7.51B, reflecting additional valuation factors such as foreign currency translation adjustments of ¥0.74B and valuation differences on securities of ¥1.79B. Because revenue growth was accompanied by an increase in working capital, particularly accounts receivable and inventories, the extent to which the increase in earnings shown on the income statement converts into cash flow will require monitoring.

Earnings Forecast and Guidance

The full-year company plan calls for Revenue of ¥149.10B (+8.2% YoY), Operating Income of ¥36.40B (+11.9%), and Ordinary Income of ¥36.30B (+12.6%). Q1 progress rates were 26.2% for Revenue, 28.9% for Operating Income, and 30.9% for Ordinary Income, all exceeding the simple one-quarter benchmark of 25%. Q1 actual growth rates—Revenue +17.6% and Operating Income +48.9%—exceeded the growth assumptions underlying the full-year plan. Taking into account that the earnings forecast was revised during the quarter, full-year progress is generally proceeding smoothly.

Shareholder Returns

For the fiscal year ending March 2027, the company plans to pay neither an interim dividend nor a year-end dividend. Accordingly, the Payout Ratio for the current period is not calculated. In addition, a 2-for-1 stock split of common shares was implemented effective December 1, 2025. Retained earnings reached ¥90.77B, indicating a substantial level of internal reserves.

Risk Factors

1. Concentration of profits in the Electronics Business: This business accounts for 91.5% of reported segment profit, and its margin has risen to 34.8%. This creates a structure in which customer production adjustments and market fluctuations can have a significant impact on the consolidated profit margin.

2. Declining working capital efficiency: Annualized DSO of 88 days, annualized DIO of 112 days, and annualized CCC of 144 days all exceed generally cautious levels. Increases in accounts receivable (+9.3%) and inventories (+6.8%) may constrain the speed at which increased revenue is converted into operating cash flow.

3. Worsening profitability in the Medical and Pharmaceutical Business: Revenue in this business declined by -2.3% YoY, while segment profit declined by -44.0%, and its margin fell from 14.6% to 8.4%. The profitability gap within the business portfolio is widening.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability is substantially above the industry median and is at a level that places the company among the leaders in the industry.

Growth and Capital Efficiency

The revenue growth rate also exceeds the upper bound of the industry IQR, demonstrating relatively high growth within the industry.

※Source: Compiled by the company

Key Points from the Earnings Results

1. The Operating Margin of 26.9%, Net Profit Margin of 19.2%, and annualized ROE of 23.8% all improved substantially from the same period of the previous year, with the higher margins in the Electronics Business driving company-wide profitability. The sustainability of this improvement will determine the quality of full-year earnings.

2. Q1 progress against the full-year plan was 28.9% for Operating Income and 30.9% for Ordinary Income, both above the standard 25% benchmark and consistent with the fact that the earnings forecast was revised during the quarter.

3. Working capital indicators of annualized DSO of 88 days, DIO of 112 days, and CCC of 144 days remain areas requiring confirmation from a cash-generation perspective despite higher revenue and profit. Attention should be paid to how the pace of increases in accounts receivable and inventories develops going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,534–¥1,627 for a ±1% change in the cost of equity, and ¥1,568–¥1,597 for a ±0.1 change in ω.

Notes:

• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).

(Calculation model: Residual income model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated values based solely on publicly disclosed data; these are not forecasts of the market share price or recommendations for specific investment actions, and do not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---